Genes mediating glucopenia-induced obesity in nematodes

介导线虫血糖减少症诱导的肥胖的基因

基本信息

项目摘要

DESCRIPTION (provided by applicant): The long-term objectives of the proposed studies are to discover genes that mediate the development of obesity in humans. Several lines of evidence suggest that neurons sensitive to the neuroendocrine effects of glucose regulate body weight, implying that attenuation of these glucose-sensing mechanisms could cause obesity. For example, attenuation of glucose sensing systems (glucopenia) by the glucose analog 2- deoxyglucose (2-DG) robustly decreases metabolic rate and increases feeding in mammals. However, molecular mechanisms mediating the effects of glucose on body weight regulation have been difficult to study in mammals and are largely not understood. Fortunately, 2-DG, which produces obese phenotypes in mammals, produces rapid and striking obesity in C. elegans. The proposed studies will therefore use RNAi in C. elegans to systematically screen for genes whose ablation blocks 2-DG-induced obesity, focusing specifically on genes which have homologs in both mammals and C. elegans. Specific Aim 1 will assess if ablation of specific genes mediating neuroendocrine regulation (G protein coupled receptors and ligand- regulated ion channels) will block glucopenia-induced obesity. Specific Aim 2 will assess if ablation of specific genes induced by hypoglycemia in mouse hypothalamus will block glucopenia-induced obesity. Specific Aim 3 will assess if ablation of specific genes induced in mouse tissues with diet-induced obesity will block glucopenia-induced obesity. Specific Aim 4 will assess if ablation of genes implicated by the first three Specific Aims in glucopenia-induced obesity will block other forms of obesity (Daf-2, etc.) in C. elegans. Conversely, Specific Aim 4 will also assess if ablation of genes implicated in other forms of obesity in C. elegans will block glucopenia-induced obesity. Of particular interest will be genes whose ablation does not produce an obvious phenotype in standard conditions, but whose ablation blocks glucopenia-induced obesity. These studies will suggest potential targets for anti-obesity drugs
描述(由申请人提供): 这些研究的长期目标是发现介导人类肥胖发展的基因。有证据表明,对葡萄糖的神经内分泌效应敏感的神经元调节体重,这意味着这些葡萄糖感知机制的减弱可能导致肥胖。例如,葡萄糖类似物2-脱氧葡萄糖(2-DG)对葡萄糖传感系统(葡萄糖减少症)的衰减强烈降低了哺乳动物的代谢率并增加了摄食。然而,调节葡萄糖对体重调节作用的分子机制在哺乳动物中很难研究,并且在很大程度上还不清楚。幸运的是,在哺乳动物中产生肥胖表型的2-DG在C.优美的因此,拟议的研究将在C中使用RNAi。elegans系统地筛选基因的消融块2-DG诱导的肥胖,特别是在哺乳动物和C.优雅的具体目标1将评估介导神经内分泌调节(G蛋白偶联受体和配体调节离子通道)的特定基因的消融是否会阻断葡萄糖减少诱导的肥胖。具体目标2将评估小鼠下丘脑中低血糖诱导的特定基因的消融是否会阻止血糖减少诱导的肥胖。具体目标3将评估在具有饮食诱导的肥胖的小鼠组织中诱导的特定基因的消融是否会阻断葡萄糖减少诱导的肥胖。具体目标4将评估在葡萄糖减少诱导的肥胖症中前三个具体目标所涉及的基因的消融是否会阻断其他形式的肥胖症(Daf-2等)。in C.优美的相反,具体目标4也将评估是否在C. elegans将阻止葡萄糖减少诱导的肥胖。特别感兴趣的是在标准条件下消融不产生明显表型,但消融阻断葡萄糖减少诱导的肥胖的基因。这些研究将为抗肥胖药物提供潜在靶点

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHARLES V MOBBS其他文献

CHARLES V MOBBS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHARLES V MOBBS', 18)}}的其他基金

Delay of Alzheimer's phenotypes by interventions that increase lifespan
通过延长寿命的干预措施延迟阿尔茨海默病表型
  • 批准号:
    10404591
  • 财政年份:
    2018
  • 资助金额:
    $ 28.8万
  • 项目类别:
Delay of Alzheimer's phenotypes by interventions that increase lifespan
通过延长寿命的干预措施延迟阿尔茨海默病表型
  • 批准号:
    9924494
  • 财政年份:
    2018
  • 资助金额:
    $ 28.8万
  • 项目类别:
Delay of Alzheimer's phenotypes by interventions that increase lifespan
通过延长寿命的干预措施延迟阿尔茨海默病表型
  • 批准号:
    9788221
  • 财政年份:
    2018
  • 资助金额:
    $ 28.8万
  • 项目类别:
Delay of Alzheimer's phenotypes by interventions that increase lifespan
通过延长寿命的干预措施延迟阿尔茨海默病表型
  • 批准号:
    10161742
  • 财政年份:
    2018
  • 资助金额:
    $ 28.8万
  • 项目类别:
Hypothalamic glucokinase in obesity and diabetes
下丘脑葡萄糖激酶在肥胖和糖尿病中的作用
  • 批准号:
    7868056
  • 财政年份:
    2009
  • 资助金额:
    $ 28.8万
  • 项目类别:
Protective role of creb-binding protein in maturation and aging
creb结合蛋白在成熟和衰老中的保护作用
  • 批准号:
    7934102
  • 财政年份:
    2009
  • 资助金额:
    $ 28.8万
  • 项目类别:
Hypothalamic glucokinase in obesity and diabetes
下丘脑葡萄糖激酶在肥胖和糖尿病中的作用
  • 批准号:
    7837536
  • 财政年份:
    2009
  • 资助金额:
    $ 28.8万
  • 项目类别:
Protective role of creb-binding protein in maturation and aging
creb结合蛋白在成熟和衰老中的保护作用
  • 批准号:
    7995976
  • 财政年份:
    2008
  • 资助金额:
    $ 28.8万
  • 项目类别:
Protective role of creb-binding protein in maturation and aging
creb结合蛋白在成熟和衰老中的保护作用
  • 批准号:
    7532528
  • 财政年份:
    2008
  • 资助金额:
    $ 28.8万
  • 项目类别:
Protective role of creb-binding protein in maturation and aging
creb结合蛋白在成熟和衰老中的保护作用
  • 批准号:
    7743460
  • 财政年份:
    2008
  • 资助金额:
    $ 28.8万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 28.8万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.8万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 28.8万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.8万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 28.8万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.8万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 28.8万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 28.8万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 28.8万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.8万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了